Acute Myeloid Leukemia Clinical Trial
Multi-center, Survival Data Collection in Subjects Previously Enrolled in Celgene Protocol CC-5013-MDS-003
Summary
Multi-center, survival data collection in subjects previously enrolled in study NCT00065156 (Celgene Protocol CC-5013-MDS-003).
Eligibility Criteria
Inclusion Criteria:
Must have been enrolled in the Celgene protocol CC-5013-MDS-003 study.
Must understand and be able to give informed consent (if a subject is deceased, proper legal consent (i.e. next of kin, legal representative) will be obtained prior to collection of data).
Exclusion Criteria:
1. Consent refused for any reason at current or long-term follow up completed in 2007 (long-term follow up: survival data collection completed to obtain further safety information on CC-5013-MDS-003 discontinued subjects from May - October 2007).
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 15 Locations for this study
Scottsdale Arizona, 85259, United States
Stanford California, 94305, United States
Lecanto Florida, 34461, United States
Tampa Florida, 33612, United States
Marietta Georgia, 30060, United States
Chicago Illinois, 60611, United States
Chicago Illinois, 60612, United States
Chicago Illinois, 60637, United States
Baltimore Maryland, 21231, United States
Rochester Minnesota, 55905, United States
New York New York, 10065, United States
Winston-Salem North Carolina, 27157, United States
Cleveland Ohio, 44195, United States
Seattle Washington, 98109, United States
Duisburg , D-471, Germany
How clear is this clinincal trial information?

Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.